ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 102,33
0,13%
Dow Jones
39 036,00
-1,60%
DAX
18 691,32
0,05%
Brent Oil
81,195
-0,41%
Bitcoin
67 273,39
-2,65%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Foamix Pharmaceuticals Ltd (FOMX)

  7. Foamix Pharmaceuticals Ltd (FOMX) Actualités

FOMX

Foamix Pharmaceuticals (FOMX)

Foamix Pharmaceuticals Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FOMX
DateHeureSourceTitreSymboleSociété
23/03/202011h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
19/03/202020h10Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202021h34Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202021h31Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202014h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/03/202012h17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/03/202012h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
09/03/202014h27Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:FOMXFoamix Pharmaceuticals Ltd
03/03/202023h02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
14/02/202023h46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
28/01/202022h01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
07/01/202022h51Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/11/201923h09PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd.NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/11/201912h18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
19/08/201922h37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
15/08/201923h11Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
06/08/201923h12Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/04/201922h25Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
11/03/201911h03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
08/03/201914h44Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
01/03/201923h04Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
14/09/201822h22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
02/04/201822h07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
01/03/201822h31Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
28/11/201722h06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
14/09/201713h00PR Newswire (US)OWC Pharma Issues Chairman's Letter to ShareholdersNASDAQ:FOMXFoamix Pharmaceuticals Ltd
24/02/201722h07Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
21/02/201722h09Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/09/201622h02Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3/a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
10/03/201601h46GlobeNewswire Inc.Foamix to Present Corporate Overview at the 36th Annual Cowen & Company Healthcare ConferenceNASDAQ:FOMXFoamix Pharmaceuticals Ltd
 Showing the most relevant articles for your search:NASDAQ:FOMX

Dernières Valeurs Consultées

NASDAQ
BLCR
BlackRock Large Cap Core...
BIT
P1TUF8
NLBNPIT1TUF8 20240621 130
EXMO
LINKUSDT
ChainLink Token
CSE
SUN
Wildflower Brands
BIT
MDC
Medica
EU
FR0014007S52
BPCE MAS HL FCT 0% 30/01...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés